NCT00102024View on ClinicalTrials.gov

Safety and Activity of 90Y-Labeled IDEC-159 in Subjects With Metastatic Colorectal Adenocarcinoma

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

January 31, 2006

Study Completion Date

January 31, 2006

Conditions
Colorectal CancerMetastases
Interventions
DRUG

Unconjugated IDEC-159

DRUG

111In-IDEC-159

DRUG

90Y-IDEC-159

Trial Locations (1)

35294-3300

University of Alabama at Birmingham, Birmingham

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY